Siemens Healthcare to showcase Hybrid molecular MR imaging solution and PET biomarkers at UK’s BNMS annual meeting


Siemens Healthcare will be highlighting the capabilities of its Biograph mMR and Symbia SPECT/CT at the British Nuclear Medicine Society’s (BNMS) annual meeting, Harrogate, UK, (29 April – 2 May 2012). PETNET Solutions, a division of Siemens, will present recent performance figures establishing it as the leading supplier of PET biomarkers in the UK in terms of volume, range and performance. 

The Biograph mMR is a hybrid molecular MR and the only system in the medical technology marketplace that combines the functionality of MR and PET in a single integrated solution. The same size of a standard 3T MRI scanner, it acquires MR functional details in human tissue and PET cellular activity in a simultaneous procedure. The Symbia SPECT/CT product family combines SPECT dual-detector variable angle gamma camera with multislice-CT capabilities for oncology, neurology and cardiology applications.

“Precision and accuracy are two key requirements in molecular imaging demanded by clinicians. Siemens Healthcare is proud to offer information on our Biograph mMR and Symbia SPECT/CT range of systems at the BNMS annual meeting,” said Lawrence Foulsham, Molecular Imaging product manager, Siemens Healthcare. “Our range delivers precision for accurate diagnosis and treatment planning, plus offers workflow advantages improving throughput and cost of ownership.”

PETNET Solutions operate two PET manufacturing and distribution sites in the UK at Mount Vernon Hospital and Nottingham City Hospital. It produces more than 20,000 doses of PET biomarkers per year with a reliability rate of on time deliveries in excess of 99.7%. The two sites provide wide UK coverage to support clinical and research PET imaging facilities.